Search Results

There are 39665 results for: content related to: Central venous access device-related infections in patients with haemophilia

  1. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland

    Haemophilia

    Volume 21, Issue 6, November 2015, Pages: 747–753, K. Vepsäläinen, R. Lassila, M. Arola, P. Lähteenmäki, M. Möttönen, A. Mäkipernaa and P. Riikonen

    Article first published online : 31 MAR 2015, DOI: 10.1111/hae.12665

  2. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: e369–e374, V. Rodriguez, M. E. Mancuso, D. Warad, C. R. M. Hay, D. M. DiMichele, L. Valentino, G. Kenet and R. Kulkarni

    Article first published online : 14 JUL 2015, DOI: 10.1111/hae.12740

  3. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator

    Haemophilia

    Volume 22, Issue 1, January 2016, Pages: 81–86, C. E. McCarthy, M. O'Brien, J. Andrews, J. M. Zoland, E. Macasiray, W. Wong, C. Lo, B. Glader, J. Tamaresis and M. Jeng

    Article first published online : 7 AUG 2015, DOI: 10.1111/hae.12772

  4. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)

    Haemophilia

    Volume 21, Issue 4, July 2015, Pages: 469–476, A. R. Langley, A. M. Stain, A. Chan, M. McLimont, S. Chait, J. Wu, M.-C. Poon, R. Card, S. J. Israels, N. Laferriere, R. J. Klaassen, G. E. Rivard, S. Cloutier, S. Hawes, B. Feldman and V. Blanchette

    Article first published online : 24 JUN 2015, DOI: 10.1111/hae.12713

  5. Consensus recommendations for use of central venous access devices in haemophilia

    Haemophilia

    Volume 10, Issue 5, September 2004, Pages: 629–648, B. M. Ewenstein, L. A. Valentino, J. M. Journeycake, M. D. Tarantino, A. D. Shapiro, V. S. Blanchette, W. K. Hoots, G. R. Buchanan, M. J. Manco-Johnson, G.-E. Rivard, K. L. Miller, S. Geraghty, J. A. Maahs, R. Stuart, T. Dunham and R. J. Navickis

    Article first published online : 1 JUL 2004, DOI: 10.1111/j.1365-2516.2004.00943.x

  6. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia

    Haemophilia

    Volume 15, Issue 6, November 2009, Pages: 1272–1280, M. R. JENG, M. O’BRIEN, W. WONG, J. ZOLAND, J. LEA, N. TANG and B. GLADER

    Article first published online : 10 JUL 2009, DOI: 10.1111/j.1365-2516.2009.02063.x

  7. Frequency of dressing changes for central venous access devices on catheter-related infections

    Intervention Review

    The Cochrane Library

    Nicole C Gavin, Joan Webster, Raymond J Chan and Claire M Rickard

    Published Online : 1 FEB 2016, DOI: 10.1002/14651858.CD009213.pub2

  8. You have free access to this content
    CVAK104 is a Novel Regulator of Clathrin-mediated SNARE Sorting

    Traffic

    Volume 8, Issue 7, July 2007, Pages: 893–903, Georg H. H. Borner, Amer A. Rana, Rebecca Forster, Michael Harbour, James C. Smith and Margaret S. Robinson

    Article first published online : 20 JUN 2007, DOI: 10.1111/j.1600-0854.2007.00576.x

  9. Central venous access devices in haemophilia

    Haemophilia

    Volume 10, Issue 2, March 2004, Pages: 134–146, L. A. Valentino, B. Ewenstein, R. J. Navickis and M. M. Wilkes

    Article first published online : 12 FEB 2004, DOI: 10.1046/j.1365-2516.2003.00840.x

  10. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis

    Haemophilia

    Volume 14, Issue 1, January 2008, Pages: 30–38, M. V. RAGNI, J. M. JOURNEYCAKE and D. J. BRAMBILLA

    Article first published online : 13 NOV 2007, DOI: 10.1111/j.1365-2516.2007.01599.x

  11. Central venous access devices for paediatric patients with haemophilia: a single-institution experience

    Haemophilia

    Volume 15, Issue 1, January 2009, Pages: 168–174, R. TITAPIWATANAKUN, C. MOIR, R. K. PRUTHI, P. L. STAVLO, K. A. SCHMIDT and V. RODRIGUEZ

    Article first published online : 8 OCT 2008, DOI: 10.1111/j.1365-2516.2008.01906.x

  12. Side-effects and venous access issues with immune tolerance therapy

    Haemophilia

    Volume 15, Issue 2, March 2009, Pages: 494–500, MANUEL D. CARCAO

    Article first published online : 29 DEC 2008, DOI: 10.1111/j.1365-2516.2008.01951.x

  13. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders

    Haemophilia

    Volume 12, Issue s6, December 2006, Pages: 87–93, P. KOMVILAISAK, B. CONNOLLY, A. NAQVI and V. BLANCHETTE

    Article first published online : 10 NOV 2006, DOI: 10.1111/j.1365-2516.2006.01371.x

  14. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia

    Haemophilia

    Volume 18, Issue 4, July 2012, Pages: 521–526, S. RANTA, T. KALAJOKI-HELMIÖ, J. POUTTU and A. MÄKIPERNAA

    Article first published online : 19 DEC 2011, DOI: 10.1111/j.1365-2516.2011.02719.x

  15. You have free access to this content
    Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 356–365, Christopher B. Benton, Deborah A. Thomas, Hui Yang, Farhad Ravandi, Michael Rytting, Susan O'Brien, Anna R. Franklin, Gautam Borthakur, Samuel Dara, Monica Kwari, Sherry R. Pierce, Elias Jabbour, Hagop Kantarjian and Guillermo Garcia-Manero

    Article first published online : 26 JUL 2014, DOI: 10.1111/bjh.13050

  16. Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocol

    Clinical Transplantation

    Volume 29, Issue 1, January 2015, Pages: 18–25, Michelle Willicombe, Nicola Kumar, Dawn Goodall, Candice Clarke, Adam G. McLean, Albert Power and David Taube

    Article first published online : 19 NOV 2014, DOI: 10.1111/ctr.12476

  17. You have free access to this content
    Development of a polyvalent RT-PCR detection assay covering the genetic diversity of Cherry capillovirus A

    Plant Pathology

    Volume 61, Issue 1, February 2012, Pages: 195–204, A. Marais, L. Svanella-Dumas, M. Barone, P. Gentit, C. Faure, G. Charlot, A. Ragozzino and T. Candresse

    Article first published online : 16 JUN 2011, DOI: 10.1111/j.1365-3059.2011.02488.x

  18. You have free access to this content
    Comparison of new conditional value-at-risk-based management models for optimal allocation of uncertain water supplies

    Water Resources Research

    Volume 43, Issue 7, July 2007, Ghina M. Yamout, Kirk Hatfield and H. Edwin Romeijn

    Article first published online : 18 JUL 2007, DOI: 10.1029/2006WR005210

  19. Surveillance of infectious complications associated with central venous access devices in children with haemophilia

    Haemophilia

    Volume 9, Issue 5, September 2003, Pages: 588–592, M. D. Tarantino, A. Lail, S. M. Donfield, H. Lynn, L. Peddle, S. Hunsberger and A. D. Shapiro

    Article first published online : 26 SEP 2003, DOI: 10.1046/j.1365-2516.2003.00793.x

  20. You have free access to this content
    Diagnosis and treatment of catheter-related infections in paediatric oncology: an update

    Clinical Microbiology and Infection

    Volume 12, Issue 7, July 2006, Pages: 606–620, A. Simon, U. Bode and K. Beutel

    Article first published online : 8 MAY 2006, DOI: 10.1111/j.1469-0691.2006.01416.x